ArriVent BioPharma Files 8-K on Shareholder Vote Matters
Ticker: AVBP · Form: 8-K · Filed: Jun 20, 2025 · CIK: 1868279
| Field | Detail |
|---|---|
| Company | Arrivent Biopharma, INC. (AVBP) |
| Form Type | 8-K |
| Filed Date | Jun 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing-update
TL;DR
ArriVent BioPharma filed an 8-K on 6/20 for a 6/18 shareholder vote. Standard corporate update.
AI Summary
ArriVent BioPharma, Inc. filed an 8-K on June 20, 2025, reporting on matters submitted to a vote of security holders on June 18, 2025. The filing details the company's corporate structure and operational information, including its principal executive offices located at 18 Campus Boulevard, Suite 100, Newtown Square, PA 19073.
Why It Matters
This filing provides essential updates on corporate governance and shareholder decisions for ArriVent BioPharma, Inc., impacting investor understanding of the company's direction.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a shareholder vote and does not appear to contain significant new financial or operational risks.
Key Players & Entities
- ArriVent BioPharma, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- June 20, 2025 (date) — Date of report
- 18 Campus Boulevard, Suite 100, Newtown Square, PA 19073 (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of ArriVent BioPharma's security holders on June 18, 2025?
The filing states that matters were submitted to a vote of security holders on June 18, 2025, but does not specify the exact nature of these matters within the provided text.
When was ArriVent BioPharma, Inc. incorporated?
ArriVent BioPharma, Inc. was incorporated in Delaware, as indicated by the filing.
What is the IRS Employer Identification Number (EIN) for ArriVent BioPharma, Inc.?
The IRS Employer Identification Number (EIN) for ArriVent BioPharma, Inc. is 86-3336099.
What is the Standard Industrial Classification (SIC) code for ArriVent BioPharma, Inc.?
The Standard Industrial Classification (SIC) code for ArriVent BioPharma, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the telephone number for ArriVent BioPharma, Inc.'s principal executive offices?
The telephone number for ArriVent BioPharma, Inc.'s principal executive offices is (628) 277-4836.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 20, 2025 regarding ArriVent BioPharma, Inc. (AVBP).